Mauritania vs Norway: Previously treated cases tested for RR-/MDR-TB
Mauritania
100.0%
in 2023
Norway
100.0%
in 2024
Mauritania rank
1st
Norway rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Mauritania
- Norway
How they compare
Mauritania currently reports 100.0% against 100.0% in Norway, a difference of 0.0%.
The two have swapped places 4 times across 13 shared years of data; in 2005 it was Norway ahead.
Mauritania ranks 1st and Norway ranks 1st of 180 countries.
Across the 3 decades both report, Mauritania averaged higher in 1 and Norway in 2.
Head to head by decade
| Decade | Mauritania | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.5% | 54.0% | 46.5% | Norway |
| 2010s | 44.7% | 61.5% | 16.8% | Norway |
| 2020s | 100.0% | 86.8% | 13.2% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Mauritania or Norway?
- Mauritania, at 100.0% against 100.0% in Norway as of 2023.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Mauritania and Norway?
- 0.0%, with Mauritania ahead.
- How many years of comparable data are there for Mauritania and Norway?
- 13 years are reported by both, from 2005 to 2023.
- How do Mauritania and Norway rank globally for previously treated cases tested for rr-/mdr-tb?
- Mauritania ranks 1st and Norway ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.